Published in J Virol on April 01, 1992
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Functional dissection of the Moloney murine leukemia virus envelope protein gp70. J Virol (1997) 2.24
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol (1999) 2.15
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med (1992) 2.12
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol (1995) 1.82
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol (1993) 1.58
Retrovirus infection: effect of time and target cell number. J Virol (1995) 1.51
Suppression of a fusion defect by second site mutations in the ecotropic murine leukemia virus surface protein. J Virol (1999) 1.35
Gibbon ape leukemia virus and the amphotropic murine leukemia virus 4070A exhibit an unusual interference pattern on E36 Chinese hamster cells. J Virol (1993) 1.35
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol (1996) 1.30
Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein. J Virol (1996) 1.26
Functional interactions between monomers of the retroviral envelope protein complex. J Virol (1997) 1.17
Mutational analysis of the fusion peptide of Moloney murine leukemia virus transmembrane protein p15E. J Virol (1998) 1.15
Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J Virol (2000) 1.09
Uses of flow cytometry in virology. Clin Microbiol Rev (1994) 1.09
Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J Virol (2001) 1.08
Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction. J Virol (1999) 1.04
Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor. J Virol (1998) 1.04
Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein. J Virol (1999) 1.04
Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo. J Virol (1998) 0.99
A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor. J Virol (1999) 0.97
Adeno-associated virus type 2-mediated transfer of ecotropic retrovirus receptor cDNA allows ecotropic retroviral transduction of established and primary human cells. J Virol (1997) 0.91
Functional characterization of the N termini of murine leukemia virus envelope proteins. J Virol (2001) 0.91
Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor. Proc Natl Acad Sci U S A (2009) 0.91
Green fluorescent protein-tagged retroviral envelope protein for analysis of virus-cell interactions. J Virol (2003) 0.90
Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines. J Virol (1998) 0.89
Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J Virol (2000) 0.88
Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus. J Virol (2006) 0.86
Pit2 assemblies at the cell surface are modulated by extracellular inorganic phosphate concentration. J Virol (2002) 0.86
Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein. J Virol (2003) 0.84
Targeted entry via somatostatin receptors using a novel modified retrovirus glycoprotein that delivers genes at levels comparable to those of wild-type viral glycoproteins. J Virol (2011) 0.84
Retracted Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro. J Virol (1996) 0.84
Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A. Virology (2012) 0.84
Identification of a critical basic residue on the ecotropic murine leukemia virus receptor. J Virol (2003) 0.83
Introduction of human genomic sequences renders CHO-K1 cells susceptible to infection by amphotropic retroviruses. J Virol (1993) 0.82
Complementation of a binding-defective retrovirus by a host cell receptor mutant. J Virol (2004) 0.82
Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry. J Virol (2005) 0.81
Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas. MAbs (2013) 0.81
Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells. J Virol (2000) 0.80
Characteristics of the cellular receptor influence the intracellular fate and efficiency of virus infection. J Virol (2013) 0.80
Removal of either N-glycan site from the envelope receptor binding domain of Moloney and Friend but not AKV mouse ecotropic gammaretroviruses alters receptor usage. Virology (2009) 0.79
Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med (1953) 25.88
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell (1977) 18.95
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol (1986) 16.65
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
Genetics of somatic mammalian cells. III. Long-term cultivation of euploid cells from human and animal subjects. J Exp Med (1958) 14.08
Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol (1969) 11.78
Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J Virol (1987) 8.81
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A (1988) 7.76
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64
Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology (1974) 6.53
Effect of internal viral sequences on the utility of retroviral vectors. J Virol (1987) 6.06
Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science (1985) 4.77
Prospects for human gene therapy. Science (1984) 3.93
Hygromycin B phosphotransferase as a selectable marker for DNA transfer experiments with higher eucaryotic cells. Mol Cell Biol (1984) 3.15
A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol (1990) 3.00
Membrane receptors for murine leukemia viruses: characterization using the purified viral envelope glycoprotein, gp71. Cell (1976) 2.93
The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. I. Establishment of interference. Virology (1966) 2.22
The mechanism of interference between an avian leukosis virus and Rous sarcoma virus. II. Early steps of infection by RSV of cells under conditions of interference. Virology (1966) 2.11
AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses. Cell (1979) 2.10
Entry of murine retrovirus into mouse fibroblasts. Virology (1983) 1.96
Infectious entry of murine retroviruses into mouse cells: evidence of a postadsorption step inhibited by acidic pH. J Virol (1985) 1.37
Retroviral vectors for introduction of genes into mammalian cells. Biotechniques (1990) 1.30
Binding characteristics of Rauscher leukemia virus envelope glycoprotein gp71 to murine lymphoid cells. J Virol (1977) 1.18
Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges. J Virol (1991) 1.17
Genetic mapping of a cloned sequence responsible for susceptibility to ecotropic murine leukemia viruses. J Virol (1990) 1.16
Cellular membrane receptors for oncovirus envelope glycoprotein: properties of the binding reaction and influence of different reagents on the substrate and the receptors. Arch Biochem Biophys (1978) 1.11
Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts. J Virol (1978) 1.08
Retroviral-mediated gene transfer. Prog Nucleic Acid Res Mol Biol (1990) 1.02
Lymphoid cell surface receptor for Moloney leukemia virus envelope glycoprotein gp71. I. Binding characteristics. J Immunol (1981) 1.00
Characterization of murine-specific leukemia virus receptor from L cells. J Virol (1986) 0.98
Adsorption, penetration, and uncoating of murine leukemia virus studied by using its reverse transcriptase. J Virol (1979) 0.95
Isolation and characterization of irradiation fusion hybrids from mouse chromosome 1 for mapping Rmc-1, a gene encoding a cellular receptor for MCF class murine retroviruses. Somat Cell Mol Genet (1991) 0.94
Specificity of cell surface virus receptors on radiation leukemia virus and radiation-induced thymic lymphomas. J Virol (1978) 0.89
The ADA human gene therapy clinical protocol. Hum Gene Ther (1990) 0.82
The N2-TIL human gene transfer clinical protocol. Hum Gene Ther (1990) 0.81
Effect of internal viral sequences on the utility of retroviral vectors. J Virol (1987) 6.06
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science (1985) 4.77
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Multiple sequence alignment. J Mol Biol (1986) 4.27
Prospects for human gene therapy. Science (1984) 3.93
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
DNA-binding proteins. Science (1983) 3.56
The molecular basis of DNA-protein recognition inferred from the structure of cro repressor. Nature (1982) 3.56
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Structural similarity in the DNA-binding domains of catabolite gene activator and cro repressor proteins. Proc Natl Acad Sci U S A (1982) 2.84
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
A mouse model for beta-thalassemia. Cell (1983) 2.70
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
Isolation and partial characterization of reticulocyte factors M1 and M2. J Biol Chem (1970) 2.59
Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. Proc Natl Acad Sci U S A (1981) 2.50
Human gene therapy. Annu Rev Biochem (1993) 2.49
Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Cell-free hemoglobin synthesis. II. Characteristics of the transfer ribonucleic acid-dependent assay system. J Biol Chem (1970) 2.24
Covalent structure of a group-specific protease from rat small intestine. Appendix: crystallographic data for a group specific protease from rat intestine. Biochemistry (1978) 2.17
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Replication and expression of thymidine kinase and human globin genes microinjected into mouse fibroblasts. Proc Natl Acad Sci U S A (1980) 2.10
Structure of the DNA-binding region of lac repressor inferred from its homology with cro repressor. Proc Natl Acad Sci U S A (1982) 2.09
Cloning and characterization of DNA sequences surrounding the human gamma-, delta-, and beta-globin genes. Proc Natl Acad Sci U S A (1980) 2.04
Translation of exogenous messenger RNA for hemoglobin on reticulocyte and liver ribosomes. Proc Natl Acad Sci U S A (1971) 2.03
Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther (1994) 1.95
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85
Purification and physical properties of homogeneous initiation factor MP from rabbit reticulocytes. J Biol Chem (1975) 1.83
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol (1995) 1.82
Many gene-regulatory proteins appear to have a similar alpha-helical fold that binds DNA and evolved from a common precursor. J Mol Evol (1983) 1.80
Translation of rabbit haemoglobin messenger RNA by thalassaemic and non-thalassaemic ribosomes. Nat New Biol (1971) 1.75
Isolation and translation of hemoglobin messenger RNA from thalassemia, sickle cell anemia, and normal human reticulocytes. J Clin Invest (1971) 1.74
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1986) 1.70
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc Natl Acad Sci U S A (1975) 1.68
Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res (1992) 1.66
Human gene therapy protocols: RAC review. Science (1995) 1.64
Nucleotide sequence of the dmsABC operon encoding the anaerobic dimethylsulphoxide reductase of Escherichia coli. Mol Microbiol (1988) 1.63
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods (1989) 1.63
Prospects for in utero human gene therapy. Science (1999) 1.61
Structural and functional homology of parvovirus and papovavirus polypeptides. J Gen Virol (1987) 1.59
Factors affecting retroviral vector function and structural integrity. Virology (1993) 1.59
Retracted Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A (1989) 1.59
Selective activation of human beta-but not gamma-globin gene in human fibroblast x mouse erythroleukaemia cell hybrids. Nature (1979) 1.58
Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol (1993) 1.58
Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med (1987) 1.57
International symposium on protein synthesis. Summary of Fogarty Center-NIH Workshop held in Bethesda, Maryland on 18-20 October, 1976. FEBS Lett (1977) 1.55
Cell-free transcription of mammalian chromatin: transcription of globin messenger RNA sequences from bone-marrow chromatin with mammalian RNA polymerase. Proc Natl Acad Sci U S A (1974) 1.54
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet (1993) 1.53
Nucleotide sequence and gene-polypeptide relationships of the glpABC operon encoding the anaerobic sn-glycerol-3-phosphate dehydrogenase of Escherichia coli K-12. J Bacteriol (1988) 1.53
Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer (2001) 1.52
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 1.51
Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy? Ophthalmology (1995) 1.50
Comparison of the structures of cro and lambda repressor proteins from bacteriophage lambda. J Mol Biol (1983) 1.48
Differential activation of the mouse beta-globin promoter by enhancers. Mol Cell Biol (1983) 1.47
Relation between hen egg white lysozyme and bacteriophage T4 lysozyme: evolutionary implications. J Mol Biol (1981) 1.46
High resolution x-ray structure of yeast hexokinase, an allosteric protein exhibiting a non-symmetric arrangement of subunits. J Mol Biol (1976) 1.45
Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J Natl Cancer Inst (1990) 1.44
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther (1993) 1.44
Role of ribosomes in streptomycin-activated suppression. Proc Natl Acad Sci U S A (1965) 1.42
Factor dependent binding of methionyl-tRNAs to reticulocyte ribosomes. Nature (1970) 1.41
Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro. J Virol (1998) 1.40
Isolation of an active transcription initiation complex from HeLa cell-free extract. Proc Natl Acad Sci U S A (1984) 1.40
Recovery of recombinant bacterial plasmids from E. coli transformed with DNA from microinjected mouse cells. Nucleic Acids Res (1981) 1.39
Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. J Virol (2001) 1.38
Characterization of the proline-rich region of murine leukemia virus envelope protein. J Virol (1998) 1.37
Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci U S A (1990) 1.36
Purification and properties of bacteriophage T4-induced RNA ligase. Arch Biochem Biophys (1976) 1.34
Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus. J Virol (1997) 1.34
Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest (1987) 1.33
Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells. Hum Gene Ther (1990) 1.32
Hemoglobin messenger RNA from human bone marrow. Isolation and translation in homozygous and heterozygous beta-thalassemia. J Clin Invest (1973) 1.32
Requirement for GTP in the initiation process on reticulocyte ribosomes and ribosomal subunits. Proc Natl Acad Sci U S A (1971) 1.32
Retroviral vectors for introduction of genes into mammalian cells. Biotechniques (1990) 1.30
The effect of tRNA concentration on the rate of protein synthesis. Proc Natl Acad Sci U S A (1969) 1.28
Cell-free hemoglobin synthesis in beta-thalassemia. Proc Natl Acad Sci U S A (1970) 1.28
Eukaryotic initiation complex formation. Evidence for two distinct pathways. J Biol Chem (1975) 1.27
Three mouse models of human thalassemia. Proc Natl Acad Sci U S A (1981) 1.27
Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther (1991) 1.27
Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J Immunol Methods (1997) 1.26
The structure of the yrdC gene product from Escherichia coli reveals a new fold and suggests a role in RNA binding. Protein Sci (2000) 1.26
Proposed alpha-helical super-secondary structure associated with protein-dna recognition. J Mol Biol (1982) 1.26
Identification of the block in targeted retroviral-mediated gene transfer. Proc Natl Acad Sci U S A (1999) 1.25
Fission yeast Rep2 is a putative transcriptional activator subunit for the cell cycle 'start' function of Res2-Cdc10. EMBO J (1995) 1.23
Mouse alpha-globin genes and alpha-globin-like pseudogenes are not syntenic. Proc Natl Acad Sci U S A (1981) 1.23
Purification and properties of rabbit reticulocyte protein synthesis elongation factor 2. J Biol Chem (1975) 1.21
Functional domains in the retroviral transmembrane protein. J Virol (1998) 1.21
Purification and characterization of homogeneous protein synthesis initiation factor M1 from rabbit reticulocytes. J Biol Chem (1975) 1.20
Structure of the lysozyme from bacteriophage T4: an electron density map at 2.4 A resolution. J Mol Biol (1978) 1.20
Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-alpha cDNA for the gene therapy of cancer in humans. J Immunol (1993) 1.19
Puromycin-peptide bond formation with reticulocyte initiation factors M1 and M2. Proc Natl Acad Sci U S A (1971) 1.19